CLINICAL_TRIALS ClinicalTrials.gov record update

Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01905046
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:37.208625+00:00
Published At: 2025-04-13T00:00:00+00:00
Record Updated At: 2025-04-13
Results Posted At: 2025-04-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Atypical Ductal Breast Hyperplasia", "BRCA1 Mutation Carrier", "BRCA2 Mutation Carrier", "Ductal Breast Carcinoma in Situ", "Lobular Breast Carcinoma in Situ"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-04-13"
protocolSection.identificationModule.nctId: "NCT01905046"
protocolSection.identificationModule.officialTitle: "Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-04-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.